Screener
Capricor Therapeutics CAPR Total debt
Total debt at other companies
Other financials
Where this comes from
Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $14.78M.
The source filing: Capricor Therapeutics’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 5:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-060382
FAQ
- What is Capricor Therapeutics's total debt?
- Capricor Therapeutics (CAPR) reported total debt of $14.78M in Q1 2026.
- How has Capricor Therapeutics's total debt changed year-over-year?
- Capricor Therapeutics's total debt increased by 1083.3% year-over-year, from $1.25M to $14.78M.
- What is the long-term trend for Capricor Therapeutics's total debt?
- Over 5 years (2020 to 2025), Capricor Therapeutics's total debt has grown at a 189.5% compound annual growth rate (CAGR), from $71.47K to $14.52M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about Capricor Therapeutics's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude